← Back to patent-cliff list
CAS 613678-03-8
(6-aminopyridin-2-yl)(1-methylpiperidin-4-yl)methanone
Codes: LASM-007
Application context (from source-drug indications)
MigraineLasmiditan hemisuccinateDrug-related adverse effects and reactionsLasmiditan hemisuccinate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Lasmiditan hemisuccinate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
piperidine-4-carboxylic acid→1-methylpiperidine-4-carboxylic acid→1-methylpiperidine-4-carbonyl chloride hydrochloride→N,N,1-trimethylpiperidine-4-carboxamide→2,6-dibromopyridine→(6-bromopyridin-2-yl)(1-methylpiperidin-4-yl)methanone→(6-aminopyridin-2-yl)(1-methylpiperidin-4-yl)methanone→2,4,6-trifluorobenzoyl chloride
(6-aminopyridin-2-yl)(1-methylpiperidin-4-yl)methanone→2,4,6-trifluorobenzoyl chloride→2-chloropyridine→N-methoxy-N,1-dimethylpiperidine-4-carboxamide→(6-chloropyridin-2-yl)(1-methylpiperidin-4-yl)methanone→diphenylmethanimine→(6-((diphenylmethylene)amino)pyridin-2-yl)(1-methylpiperidin-4-yl)methanone
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.